UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
...nal facilities for bioinformatics, and world-class multi modality imaging facilities for analysis of stem cell therapies in laboratory models and, ultimately, in patients enrolled in clinical trials. "UCLA encourages strong collaborations between faculty in the life sciences and the health sciences," said...Experimental TB drug effective against resistant and latent mycobacterium tuberculosis
...uberculosis drug may be effective against not only multi drug-resistant forms of the disease but could also be the first compound to treat the latent stage of infection as well. Researchers report their results today at the 2006 ASM Biodefense Research Meeting. "The class of which this compound is the l...